Table 1 Baseline characteristics for the COACH group and the CONTROL group

Sex (n,%)

 Male

 Female

9 (20%)

37 (80%)

12 (24%)

38 (76%)

Age (years)

52.9 ± 10.4

55.3 ± 12.5

Body mass index (kg/m²)

28.0 ± 5.0

26.6 ± 4.2

Cancer type (n,%)

 Breast cancer

 Lung cancer

 Leukemia

 Lymphomas

 Colorectal cancer

 Head- and neck cancer

 Other

27 (59%)

2 (4%)

2 (4%)

4 (9%)

3 (7%)

-

8 (17%)

26 (52%)

5 (10%)

2 (4%)

1 (2%)

1 (2%)

3 (6%)

12 (24%)

Metastasis (n, %)

 Lymphatic metastasis

 Distant metastasis

 No metastasis

7 (16%)

3 (7%)

36 (78%)

17 (34%)

1 (2%)

32 (64%)

Treatment (n,%)

 Surgery

 Chemotherapy

 Radiotherapy

 Hormone therapy

 Immunotherapy

 Stem cell transplantation

38 (83%)

29 (63%)

23 (50%)

15 (33%)

8 (17%)

2 (4%)

41 (82%)

29 (58%)

28 (56%)

16 (32%)

7 (14%)

1 (2%)

Time since active medical treatment (months)

7.5 ± 6.1

6.3 ± 4.0

Comorbidity (n,%)

 Cardiovascular

 Respiratory

 Musculoskeletal

 Psychological

10 (22%)

1 (2%)

11 (24%)

4 (9%)

11 (22%)

5 (10%)

19 (38%)

7 (14%)

Self-reported exercise history before diagnosis (hours/week)

5 ± 5

6 ± 7

Employed before diagnose

38 (83%)

39 (78%)

Weekly physical activity T0 (min) ^A

848 ± 256

894 ± 256

Peak oxygen uptake T0 (mL/kg/min)

22.3 ± 6.1

22.7 ± 6.1

Quality of life (EORTC-QLQ-C30 sum score)

73.1 ± 15.6

74.6 ± 15.3

Fatigue (MFI-20 sum score)

57 ± 15

54 ± 18

Anxiety and Depression (HADS sum score)

11 ± 6

12 ± 8